JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, N.
Right arrow Articles by Reid, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, N.
Right arrow Articles by Reid, I. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram

N Chiu, I Park and IA Reid

Department of Physiology, University of California, San Francisco, USA.

It is now generally accepted that the renin secretory response to beta adrenoceptor stimulation is mediated by increased formation of cAMP in the juxtaglomerular cells. It is also known that renin secretion is increased when cAMP metabolism is decreased by phosphodiesterase inhibitors such as theophylline, but it is not known which isoforms of phosphodiesterase are involved. In the present study, we investigated the effect on renin secretion of the phosphodiesterase IV inhibitor rolipram in conscious rabbits. The i.v. administration of rolipram in a dose of 25 microgram/kg followed by infusion at 5 microgram/kg/min in eight rabbits increased mean arterial pressure from 82 +/- 5 to 93 +/- 6 mm Hg (P<.05), decreased HR from 242 +/- 7 to 204 +/- 10 bpm (P<.05) and increased plasma renin activity (PRA) from 6.9 +/- 1.3 to 29.0 +/- 4.2 ng/ml/2 h (P<.01). In a second series of experiments, i.v. infusion of isoproterenol at 0.05 microgram/kg/min increased PRA from 4.1 +/- 0.9 to 9.9 +/- 1.2 ng/ml/2 h (P<.01). Administration of rolipram again increased PRA, and infusion of isoproterenol in the presence of rolipram increased PRA from 30.2 +/- 7.0 to 58.9 +/- 12.6 ng/ml/2 h (P<.01), an increase significantly greater (P<.05) than that produced by isoproterenol alone. Rolipram also prolonged the PRA and HR responses to isoproterenol. These results demonstrate that inhibition of phosphodiesterase IV increases renin secretion and potentiates the renin secretory response to beta adrenoceptor stimulation, thus providing evidence for a role of phosphodiesterase IV in the regulation of renin secretion.

Volume 276, Issue 3, pp. 1073-1077, 03/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
U. G. Friis, B. L. Jensen, F. Jorgensen, D. Andreasen, and O. Skott
Electrophysiology of the renin-producing juxtaglomerular cells
Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1287 - 1290.
[Full Text] [PDF]


Home page
Circ. Res.Home page
U. G. Friis, B. L. Jensen, S. Sethi, D. Andreasen, P. B. Hansen, and O. Skott
Control of Renin Secretion From Rat Juxtaglomerular Cells by cAMP-Specific Phosphodiesterases
Circ. Res., May 17, 2002; 90(9): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. J. Chiu, S.-H. Hu, and I. A. Reid
Inhibition of Phosphodiesterase III with Milrinone Increases Renin Secretion in Human Subjects
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 16 - 19.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Kurtz, K.-H. Gotz, M. Hamann, and C. Wagner
Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3
PNAS, April 14, 1998; 95(8): 4743 - 4747.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.